NWF Advisory Services’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,455
Closed -$280K 344
2024
Q1
$280K Buy
7,455
+3,239
+77% +$142K 0.05% 236
2023
Q4
$236K Buy
+4,216
New +$183K 0.05% 234
2023
Q3
Sell
-4,299
Closed -$240K 303
2023
Q2
$240K Hold
4,299
0.06% 213
2023
Q1
$240K Buy
+4,299
New +$201K 0.06% 212

Other funds holding TXG

NWF Advisory Services's TXG Position: Q2 2024 in Review

NWF Advisory Services sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 7,455 shares — an estimated $280K sold.

NWF Advisory Services first reported a position in TXG in Q1 2023 and held it in 4 quarters. The position peaked at $280K in Q1 2024. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • NWF Advisory Services reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • NWF Advisory Services sold 7,455 10x Genomics shares in Q2 2024, an estimated $280K.
  • NWF Advisory Services first reported a position in 10x Genomics in Q1 2023 and held it in 4 quarters.
  • NWF Advisory Services's 10x Genomics position peaked at $280K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on NWF Advisory Services's 13F filing for Q2 2024, filed 6 Oct 2025.